Fig. 1From: SARS-COV-2 infection outcomes in patients with congenital generalized lipodystrophyAge range and median age (in red) of in CGL patients with reactive (SARS-COV-2+) and non-reactive serologic tests for SARS-CoV-2 infection (SARS-COV-2−) (n = 22, p = 0.355)Back to article page